AU621203B2 - Sodium n-acetylneuraminate trihydrate and method for the preparation thereof - Google Patents

Sodium n-acetylneuraminate trihydrate and method for the preparation thereof

Info

Publication number
AU621203B2
AU621203B2 AU50776/90A AU5077690A AU621203B2 AU 621203 B2 AU621203 B2 AU 621203B2 AU 50776/90 A AU50776/90 A AU 50776/90A AU 5077690 A AU5077690 A AU 5077690A AU 621203 B2 AU621203 B2 AU 621203B2
Authority
AU
Australia
Prior art keywords
sodium
acetylneuraminate
trihydrate
preparation
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU50776/90A
Other versions
AU5077690A (en
Inventor
Kenji Abiko
Motoaki Goto
Shikoh Minagawa
Hideo Mizu
Kinichi Saito
Naokazu Sugiyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mect Corp
Original Assignee
KANTO ISHI PHARMA CO Ltd
Mect Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KANTO ISHI PHARMA CO Ltd, Mect Corp filed Critical KANTO ISHI PHARMA CO Ltd
Publication of AU5077690A publication Critical patent/AU5077690A/en
Application granted granted Critical
Publication of AU621203B2 publication Critical patent/AU621203B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06Aminosugars
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/10Expectorants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Sodium N-acetylneuraminate trihydrate herein provided is represented by the following formula: <CHEM> The sodium N-acetylneuraminate trihydrate can be prepared, for instance, according to a method which comprises the steps of: dissolving sodium N-acetylneuraminate in water or in a mixture of water and an organic solvent; allowing the resulting solution to stand; precipitating and separating the resulting crystals of sodium N-acetylneuraminate . trihydrate; and then drying the separated crystals. The sodium N-acetylneuraminate trihydrate has very low hygroscopicity and hence can be handled without any difficulty in the form of powder.
AU50776/90A 1989-03-08 1990-03-07 Sodium n-acetylneuraminate trihydrate and method for the preparation thereof Ceased AU621203B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1055388A JP2745059B2 (en) 1989-03-08 1989-03-08 Sodium N-acetylneuraminate trihydrate
JP1-55388 1989-03-08

Publications (2)

Publication Number Publication Date
AU5077690A AU5077690A (en) 1990-09-20
AU621203B2 true AU621203B2 (en) 1992-03-05

Family

ID=12997127

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50776/90A Ceased AU621203B2 (en) 1989-03-08 1990-03-07 Sodium n-acetylneuraminate trihydrate and method for the preparation thereof

Country Status (16)

Country Link
US (1) US5231177A (en)
EP (1) EP0386721B1 (en)
JP (1) JP2745059B2 (en)
KR (1) KR0128369B1 (en)
CN (1) CN1026982C (en)
AT (1) ATE118217T1 (en)
AU (1) AU621203B2 (en)
CA (1) CA2011468C (en)
DE (1) DE69016683T2 (en)
DK (1) DK0386721T3 (en)
ES (1) ES2067580T3 (en)
FI (1) FI95267C (en)
HU (1) HU203247B (en)
IL (1) IL93670A (en)
NO (1) NO173701C (en)
NZ (1) NZ232806A (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI291462B (en) 2000-04-25 2007-12-21 Daiichi Sankyo Co Ltd Hydrate crystal of neuraminic acid compound
JP5523313B2 (en) 2007-07-03 2014-06-18 チルドレンズ ホスピタル アンド リサーチ センター アット オークランド Polysialic acid derivatives, methods of manufacture, and use in enhancing and targeting cancer antigen production
US9333247B2 (en) * 2007-07-03 2016-05-10 Children's Hospital & Research Center At Oakland Oligosialic acid derivatives, methods of manufacture, and immunological uses
US8999954B2 (en) * 2007-07-03 2015-04-07 Childern's Hospital & Research Center at Oakland Inhibitors of polysialic acid de-N-acetylase and methods for using the same
EP2960237A1 (en) * 2011-12-16 2015-12-30 Daiichi Sankyo Company, Limited Method for producing neuraminic acid derivative
JP6867806B2 (en) * 2014-07-30 2021-05-12 協和発酵バイオ株式会社 Crystals of N-acetylneuraminic acid alkali metal salt / anhydrate and its production method
ES2777838T3 (en) * 2015-01-28 2020-08-06 Kyowa Hakko Bio Co Ltd Ammonium N-acetylneuraminate anhydrate crystal and procedure to produce the same
CN109180749B (en) * 2018-10-18 2022-04-22 中国科学院合肥物质科学研究院 Method for preparing high-purity N-acetylneuraminic acid hydrate by using supersaturation crystallization method
CN109232677B (en) * 2018-10-18 2021-12-28 中国科学院合肥物质科学研究院 Method for converting N-acetylneuraminic acid hydrate into N-acetylneuraminic acid
CN109265497B (en) * 2018-10-18 2022-04-19 武汉中科光谷绿色生物技术有限公司 Method for preparing N-acetylneuraminic acid by converting N-acetylneuraminic acid hydrate by using organic solvent
CN110606863B (en) * 2019-10-08 2023-05-30 中国科学院合肥物质科学研究院 Preparation method of N-acetylneuraminic acid dihydrate
CN110627849B (en) * 2019-10-15 2023-02-17 中国科学院合肥物质科学研究院 Preparation method of N-acetylneuraminic acid standard substance

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8002823A (en) * 1980-05-14 1981-12-16 Amsterdam Chem Comb LACTITOL MONOHYDRATE AND METHOD FOR PREPARING CRYSTALLINE LACTITOL.
JPS6053039B2 (en) * 1981-06-26 1985-11-22 メクト株式会社 N-Acetyl/Iramic acid derivative and method for producing the same
AU582758B2 (en) * 1984-06-28 1989-04-13 Mect Corporation Sialic acid derivatives, galactose derivatives and method for producing the same
JPS61103889A (en) * 1984-10-24 1986-05-22 Hayashibara Biochem Lab Inc Crystalline erlose, honey-containing crystal containing said compound, their preparation and use
JPS6344590A (en) * 1986-08-12 1988-02-25 Mect Corp Production of sialic acid derivative
IT1223398B (en) * 1987-12-01 1990-09-19 Sirac Spa PROCEDURE FOR THE PREPARATION OF HIGH PURITY CRYSTALLINE LACTULOSE
JPH01299294A (en) * 1988-05-24 1989-12-04 Mect Corp 4,8-anhydro-n-acetyleuramic acid derivative
DE68912721T2 (en) * 1988-11-16 1994-05-11 Nippon Kayaku Kk Crystalline hydrochloride of an etoposide-2-dimethylamino compound and process for producing the same.

Also Published As

Publication number Publication date
DE69016683T2 (en) 1995-06-08
NZ232806A (en) 1991-10-25
HUT53117A (en) 1990-09-28
HU203247B (en) 1991-06-28
US5231177A (en) 1993-07-27
CA2011468A1 (en) 1990-09-08
FI95267C (en) 1996-01-10
DK0386721T3 (en) 1995-07-10
JP2745059B2 (en) 1998-04-28
JPH02235897A (en) 1990-09-18
IL93670A (en) 1994-08-26
HU901346D0 (en) 1990-05-28
ES2067580T3 (en) 1995-04-01
ATE118217T1 (en) 1995-02-15
KR0128369B1 (en) 1998-04-03
CN1026982C (en) 1994-12-14
NO901084D0 (en) 1990-03-07
FI95267B (en) 1995-09-29
CN1045584A (en) 1990-09-26
NO901084L (en) 1990-09-10
DE69016683D1 (en) 1995-03-23
NO173701C (en) 1994-01-19
FI901150A0 (en) 1990-03-07
AU5077690A (en) 1990-09-20
KR900014419A (en) 1990-10-23
CA2011468C (en) 1996-09-10
EP0386721A1 (en) 1990-09-12
NO173701B (en) 1993-10-11
EP0386721B1 (en) 1995-02-08

Similar Documents

Publication Publication Date Title
DE3362784D1 (en) Process for preparing free-flowing ethylcellulose microcapsules
CA2090967A1 (en) Water soluble camptothecin analogues, processes and methods
AU621203B2 (en) Sodium n-acetylneuraminate trihydrate and method for the preparation thereof
IE873006L (en) Salt of diclofenac with a cyclic organic base and¹pharmaceutical compositions which contain it
KR940009194A (en) Method for preparing clavulanate potassium salt
MX9603204A (en) Process for the preparation of a salt of clavulanic acid.
CA2146708A1 (en) Process for producing glutamine derivative
JPS6440467A (en) Novel substituted diphenylimidazole derivative
HUT47091A (en) Process for producing tetrahydrobenzthiazols
JPS57203049A (en) Preparation of amide derivative
KR840001178A (en) Preparation of N-methyl-D-glucamine Salts
IE802221L (en) Process for preparing a thiazolidinedione derivative
JPS5212146A (en) Process for preparation of p- acetylaminobenzene-sufonylchloride
ES8206522A1 (en) Process for the Preparation of Apovincaminic Acid Esters
JPS5436274A (en) Preparation of propiophenone derivative
JPS5687590A (en) Diphosphoglycerine derivative
JPS5266685A (en) Purification and separarion of 2-keto-l-glonic acid
JPS5756482A (en) Ampicillin ester and its preparation
JPS5365867A (en) Preparation of chenodeoxycholic acid crystal
JPS5268102A (en) Preparation ofn-acylamino acid derivative solution
JPS56113750A (en) Preparation of n-acetyl-l-glutamine aluminum salt
JPS53112868A (en) Production of thienylacetic acid derivative
JPS52153937A (en) Preparation of novel phenylalanine derivatives
JPS57142971A (en) Preparation of 4-(3-isopropylamino-2-hydroxy-propoxy) indole
JPS5412346A (en) Preparation of alpha-aminocyclohexanone oxime hydrochloride